FiercePharma  Aug 24  Comment 
Despite strong opposition from international nonprofit group Médecins Sans Frontières and local company Panacea Biotec, India's patent office has granted Pfizer a patent for its blockbuster pneumococcal vaccine Prevnar 13.
NPR  Aug 14  Comment 
Chenai Mathabire dreamed of being a model, but life had different plans. She recently won an award for proving that a rapid TB test could be used successfully in clinics across southeastern Africa.
The Hindu Business Line  Jun 23  Comment 
PATENT INJUSTICEPlea to Modi on affordable drugsAhead of US President Donald Trump and Prime Minister Narendra Modi’s meeting at the White House, Doctors Without Borders/Médecins Sans Frontières (MSF)...
FiercePharma  Apr 18  Comment 
With new online tool, MSF invites Pfizer, GSK investors to weigh in on vaccine pricing esagonowsky Tue, 04/18/2017 - 14:57
The Economic Times  Apr 7  Comment 
The RBI has shifted its policy focus to liquidity management by raising reverse repo rate by 25 bps and slashing MSF by an equal measure.
The Economic Times  Apr 6  Comment 
The central bank turned hawkish on inflation this time around. For 2017-18, it projected inflation to average at 4.5 per cent in the first half of the year.
FiercePharma  Mar 27  Comment 
Gilead's Sovaldi patent under fire again from MSF coalition, this time in Europe esagonowsky Mon, 03/27/2017 - 10:12
FiercePharma  Feb 14  Comment 
Pfizer, GSK targeted for vaccine pricing in MSF Twitter spree esagonowsky Tue, 02/14/2017 - 16:12
DailyFinance  Jan 17  Comment 
Filed under: News, Conflict & Extremism MAIDUGURI, Nigeria Jan 17 (Reuters) - Nigeria's air force killed 50 people and injured 120 in an air strike on a refugee camp in the northeast on Tuesday, Medecins Sans Frontieres (MSF) said. The...
Financial Times  Dec 13  Comment 
In the western hemisphere's poorest country, MSF clinic is the difference between life and death


Morgan Stanley Emerging Markets Fund, Inc. (MSF)

Closed-end investment companies like the Morgan Stanley Emerging Markets Fund, Inc. do not continuously offer shares to the public. Growth results from market appreciation, which benefits its shareholders. Wide dispersion that results from global diversification, reduces volatility, which gives the shareholder greater safety.

The Emerging Markets Equity team consists of portfolio managers and analysts, headed by James Cheng, and, Ana Cristina Piedrahita. The fund compares its performance to, the Morgan Stanley Capital International (MSCI) Emerging Markets Index, also run by Morgan Stanley. An emerging country as used by the company, is any country that The World Bank or similar major financial institution has determined to have a low or middle economy, or countries included in their own Index.

Shares of Morgan Stanley Emerging Markets Fund, Inc. (MSF) is traded on the New York Stock Exchange under the symbol “MSF.” Its investment objective is long-term capital appreciation through investments primarily in emerging country equity securities. The Fund may invest its assets in foreign real estate companies. It invests in industries, such as commercial banks, wireless telecommunication services, oil, gas and consumable fuels, insurance, pharmaceuticals, electric utilities, tobacco and semiconductors and semiconductor equipment. The Fund invests in the Morgan Stanley Institutional Liquidity Funds-Money Market Portfolio (the Liquidity Funds), a mutual fund managed by the Adviser. The Fund invests in Morgan Stanley Growth Fund, a mutual fund advised by an affiliate of the Adviser. As a result, the Fund and its stockholders, in effect, may be absorbing duplicate levels of fees with respect to investments in mutual funds. The Templeton Russia Fund (TRF) distributes essentially all of its realized income, and capital gains to shareholders each year.

The only other emerging market closed-end fund on the NYSE, is the older Templeton Emerging Markets Fund (NYSE: EMF) [1]

Mark Mobius "World Outlook 2010" [2]

Morgan Stanley Investment Management Inc. 522 Fifth Avenue New York, New York 10036 [3]


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki